Abbott Laboratories (ABT) Stock Price Today
Aura AI Summary
Key Stats
- $182.59BMarket Cap
- -Volume
- HealthSector
- $136.6252W High
- $82.5752W Low
- -Typical Hold Time
- $209.60BEnterprise Value
- 2.39%Div Yield
- -Trading Activity
Track Abbott Laboratories (ABT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Abbott Laboratories has traded between a low of $82.57 and a high of $136.62, highlighting its annual price range. Buy and sell Abbott Laboratories shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Most Recent News
Norwegian Cruise shares drop 3% as rising oil prices hurt fuel-cost outlook
Shares of Norwegian Cruise Line fell 3% due to rising oil prices, which increase fuel costs and pressure profit margins. Carnival and Royal Caribbean stocks also declined but less sharply, as Norwegian's higher debt and smaller scale make it more vul...
GE Aerospace's $12B acquisition of Consolidated Precision Products boosts defense supply chain and stock outlook.
GE Aerospace is acquiring Consolidated Precision Products for nearly $12 billion to bring its jet engine castings supply in-house, addressing a key manufacturing bottleneck. This move strengthens GE's defense segment, which showed strong revenue grow...
UiPath shares drop 3% despite Citi's Buy rating and $23 target amid mixed investor sentiment.
UiPath shares fell 3% to $13.55 even after Citi initiated coverage with a Buy rating and a $23 price target, citing UiPath's role in AI orchestration. The decline follows a third-quarter revenue guide below expectations, causing investor caution desp...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.